Ignite Creation Date:
2025-12-24 @ 6:34 PM
Ignite Modification Date:
2025-12-31 @ 2:46 AM
Study NCT ID:
NCT00353457
Status:
TERMINATED
Last Update Posted:
2020-04-09
First Post:
2006-07-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Capecitabine,Oxaliplatin & Erbitux Given Throughout Multi-Modal Therapy for Locally Advanced Rectal Adenocarcinoma
Sponsor:
Abramson Cancer Center at Penn Medicine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-02
Start Date Type:
ACTUAL
Primary Completion Date:
2011-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-06
Completion Date Type:
ACTUAL
First Submit Date:
2006-07-14
First Submit QC Date:
None
Study First Post Date:
2006-07-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2020-04-09
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2020-04-06
Last Update Post Date:
2020-04-09
Last Update Post Date Type:
ACTUAL